While pertussis has been on the rise since 2000, as of 2015, primary series compliance rates for ≥3 doses of DTaP remain high at 95%1,2
Note: surveillance data have limitations and are often incomplete; more than one-third of pertussis cases in 2017 among children 6 months to 6 years of age had unknown pertussis vaccination history. These data cannot be used to interpret vaccine effectiveness or to assess risk, as the data are incomplete and there is no healthy comparison group.
Source: Centers for Disease Control and Prevention. 2017 Final Pertussis Surveillance Report from the National Notifiable Diseases Surveillance System (NNDSS).1
DTaP=diphtheria, tetanus, and acellular pertussis.
References: 1. Pertussis (whooping cough): surveillance and reporting. Centers for Disease Control and Prevention website. http://www.cdc.gov/pertussis/surv-reporting.html. Updated July 11, 2018. Accessed September 4, 2019. 2. Liang JL, Tiwari T, Moro P, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2018;67(RR-2):1-44.